tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Ravi Misra, 2 are a BUY (33.33%), 1 are a SELL (16.67%), 3 are a HOLD (50%).
Analyst Ravi Misra, carries an average stock price target met ratio of 58.33% that have a potential upside of 15.16% achieved within 160 days. Previously, Ravi Misra worked at BERENBERG.
Ravi Misra’s has documented 21 price targets and ratings displayed on 4 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on INSP, Inspire Medical Systems at 26-Nov-2025.
Analyst best performing recommendations are on TDOC (TELADOC).
The best stock recommendation documented was for TDOC (TELADOC) at 11/1/2022. The price target of $33 was fulfilled within 10 days with a profit of $4.12 (14.27%) receiving and performance score of 14.27.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$181
$33.77 (22.94%)
$199
1 months 12 days ago
(30-Oct-2025)
0/4 (0%)
$42.57 (30.75%)
Buy
$200
$52.77 (35.84%)
$190
1 months 12 days ago
(30-Oct-2025)
14/39 (35.9%)
$61.57 (44.48%)
93
Buy
$170
$22.77 (15.47%)
$160
1 months 12 days ago
(30-Oct-2025)
6/16 (37.5%)
$31.57 (22.81%)
239
Hold
$155
$7.77 (5.28%)
$215
1 months 26 days ago
(16-Oct-2025)
10/18 (55.56%)
$25.16 (19.38%)
123
Buy
$170
$22.77 (15.47%)
$245
1 months 29 days ago
(13-Oct-2025)
11/14 (78.57%)
$40.46 (31.23%)
332
Which stock is Ravi Misra is most bullish on?
What Year was the first public recommendation made by Ravi Misra?
